#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4044	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2479	452.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1518	1518	C	540	C,A	416,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4115	442.1	0	.	n	.	0	T695C	SNP	695	695	T	1216	1216	C	547	C	439	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4115	442.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1858	1858	A	541	A	447	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4115	442.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2492	2492	C	470	C,T,A	379,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4115	442.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2566	2566	A	472	A	402	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6484	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4115	442.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3118	3118	C	482	C	374	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	27	580	folP	852	852	100.0	folP.l6.c17.ctg.1	2064	76.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1257	1259	AGC	105;104;108	A;G;C	81;81;80	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1374	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3816	101.1	1	SNP	p	S91F	1	.	.	271	273	TTC	779	781	TTC	94;93;92	T;T;C	77;75;75	gyrA.WHO_Z_01155:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1374	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3816	101.1	1	SNP	p	N95G	0	.	.	283	285	AAC	791	793	AAC	91;91;91	A;A;C	76;74;74	gyrA.WHO_Z_01155:1:1:N95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_Z_01155	gyrA.WHO_Z_01155	1	1	27	1374	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3816	101.1	1	SNP	p	D95N	1	.	.	283	285	AAC	791	793	AAC	91;91;91	A;A;C	76;74;74	gyrA.WHO_Z_01155:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	582	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1741	94.6	1	SNP	p	G45D	1	.	.	133	135	GAC	650	652	GAC	159;159;159	G;A,C;C	124;122,1;122	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	424	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1227	95.3	0	.	n	.	0	A197.	DEL	197	197	A	715	715	A	163	A	131	.	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3309	107.0	1	SNP	p	D86N	0	.	.	256	258	GAC	737	739	GAC	105;105;106	G;A;C,A	81;81;88,1	parC.WHO_X_00208c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3309	107.0	1	SNP	p	S87R	1	.	.	259	261	CGT	740	742	CGT	106;106;106	C,T;G;T,G	85,1;85;85,1	parC.WHO_X_00208c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3309	107.0	1	SNP	p	R87W	0	.	.	259	261	CGT	740	742	CGT	106;106;106	C,T;G;T,G	85,1;85;85,1	parC.WHO_X_00208c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3309	107.0	1	SNP	p	R87I	0	.	.	259	261	CGT	740	742	CGT	106;106;106	C,T;G;T,G	85,1;85;85,1	parC.WHO_X_00208c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_X_00208c	parC.WHO_X_00208c	1	1	27	1246	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3309	107.0	1	SNP	p	S88P	1	.	.	262	264	CCC	743	745	CCC	106;107;106	C;C;C	86;92;88	parC.WHO_X_00208c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1178	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2956	111.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1706	1708	GGC	125;125;125	G;G;C	96;96;95	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1390	1392	GCC	150;149;149	G;C;C	115;112;108	penA.10.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1393	1395	ATG	147;146;146	A,C;T;G	113,1;113;113	penA.10.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1405	1407	ACC	151;151;151	A,C;C;C	116,1;115;117	penA.10.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1405	1407	ACC	151;151;151	A,C;C;C	116,1;115;117	penA.10.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1906	1908	ACC	137;137;136	A;C;C	113;113;109	penA.10.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1960	1962	GCG	132;131;133	G;C;G	103;98;101	penA.10.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1960	1962	GCG	132;131;133	G;C;G	103;98;101	penA.10.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2083	2085	GGT	140;142;143	G;G;T	119;119;119	penA.10.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2092	2094	AGC	138;138;136	A;G;C	115;117;116	penA.10.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	1112	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2754	113.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2110	2112	CCG	142;141;141	C;C;G	124;124;120	penA.10.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1426	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3562	112.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1793	1795	CCG	101;100;101	C;C;G	81;78;78	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	614	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2160	79.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	713	713	C	100	C	79	.	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	950	porB1b	1047	1047	99.81	porB1b.l15.c17.ctg.1	1813	136.9	0	.	p	.	0	G38E	NONSYN	112	114	GGA	710	712	GAA	201;201;201	G;A;A	157;160;161	.	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	950	porB1b	1047	1047	99.81	porB1b.l15.c17.ctg.1	1813	136.9	0	.	p	.	0	D333E	NONSYN	997	999	GAC	1595	1597	GAA	194;192;192	G,T;A;A	147,1;149;148	.	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	950	porB1b	1047	1047	99.81	porB1b.l15.c17.ctg.1	1813	136.9	1	SNP	p	G120K	1	.	.	358	360	AAG	956	958	AAG	172;171;171	A;A,G;G	136;141,1;141	porB1b.WHO_K_02195c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	950	porB1b	1047	1047	99.81	porB1b.l15.c17.ctg.1	1813	136.9	1	SNP	p	A121D	1	.	.	361	363	GAC	959	961	GAC	169;169;171	G;A;C,A	138;130;129,2	porB1b.WHO_K_02195c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_K_02195c	porB1b.WHO_K_02195c	1	1	539	950	porB1b	1047	1047	99.81	porB1b.l15.c17.ctg.1	1813	136.9	1	SNP	p	D121N	0	.	.	361	363	GAC	959	961	GAC	169;169;171	G;A;C,A	138;130;129,2	porB1b.WHO_K_02195c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2416	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5521	122.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	418	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1238	93.3	1	SNP	p	V57M	1	.	.	169	171	ATG	587	589	ATG	168;168;171	A;T;G,T	127;131;128,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
